ClassID:

108893

C12N9/1018 - CPC Classification

Classification description:

Enzymes; Proenzymes; Compositions thereof ; Processes for preparing, activating, inhibiting, separating or purifying enzymes; Transferases (2.) transferring one-carbon groups (2.1) Carboxy- and carbamoyl transferases (2.1.3)

Recent Application in this class:
#1
20260078356
2026-03-19

COMPOSITIONS AND METHODS FOR TREATING ORNITHINE TRANSCARBAMYLASE DEFICIENCY

#2
20250339480
2025-11-06

ADENO-ASSOCIATED VIRUS VIRION FOR TREATING ORNITHINE TRANSCARBAMYLASE DEFICIENCY

#3
20250333751
2025-10-30

MICROORGANISM WITH L-ORNITHINE PRODUCTION CAPABILITY AND METHOD FOR PRODUCING L-ORNITHINE USING SAME

#4
20250277226
2025-09-04

IMPROVED BIOTECHNOLOGICAL METHOD FOR PRODUCING GUANIDINO ACETIC ACID (GAA) BY INACTIVATION OF AN AMINO ACID EXPORTER

#5
20250223573
2025-07-10

METHODS OF ALTERING SEED WEIGHT AND SEED OIL CONTENT BY MANIPULATING ALPHA-CARBOXYL-TRANSFERASE (A-CT) ACTIVITY VIA CARBOXYL-TRANSFERASE INTERACTION (CTI) PROTEIN EXPRESSION

#6
20250207161
2025-06-26

L-AMINO ACID-PRODUCING MICROORGANISM HAVING WEAKENED CARBAMOYL PHOSPHATE SYNTHASE ACTIVITY, AND L-AMINO ACID PRODUCTION METHOD USING SAME

#7
20250163481
2025-05-22

IMPROVED BIOTECHNOLOGICAL METHOD FOR PRODUCING GUANIDINO ACETIC ACID (GAA) BY USING NADH-DEPENDENT DEHYDROGENASES

#8
20250136953
2025-05-01

COMPOSITIONS AND METHODS FOR THE TREATMENT OF ORNITHINE TRANSCARBAMYLASE DEFICIENCY

#9
20250092431
2025-03-20

Method for Regulating and Controlling Heterologous Synthetic Flavonoid Compound and Use Thereof

#10
20240316130
2024-09-26

COMPOSITION AND METHODS INCLUDING RECOMBINANT VIRUSES MODULATING ARGININE BIOSYNTHESIS

#11
20240247239
2024-07-25

POLYNUCLEOTIDES ENCODING ORNITHINE TRANSCARBAMYLASE FOR THE TREATMENT OF UREA CYCLE DISORDERS

#12
20240189449
2024-06-13

LIPID NANOPARTICLES AND POLYNUCLEOTIDES ENCODING ORNITHINE TRANSCARBAMYLASE FOR THE TREATMENT OF ORNITHINE TRANSCARBAMYLASE DEFICIENCY

#13
20240158833
2024-05-16

Compositions and Methods for Labeling Modified Nucleotides in Nucleic Acids

#14
20240002815
2024-01-04

COMPOSITIONS AND METHODS FOR TREATING ORNITHINE TRANSCARBAMYLASE DEFICIENCY

#15
20230416700
2023-12-28

COMPOSITIONS USEFUL IN TREATMENT OF ORNITHINE TRANSCARBAMYLASE (OTC) DEFICIENCY

#16
20230104091
2023-04-06

COMPOSITIONS AND METHODS FOR THE TREATMENT OF METABOLIC LIVER DISORDERS

#17
20230001021
2023-01-05

ORNITHINE TRANSCARBAMYLASE (OTC) CONSTRUCTS AND METHODS OF USING THE SAME

#18
20220267816
2022-08-25

Production of malonyl-COA derived products via anaerobic pathways

#19
20220073944
2022-03-10

MULTIMERIC CODING NUCLEIC ACID AND USES THEREOF

#20
20220054602
2022-02-24

mRNA FOR USE IN TREATMENT OF HUMAN GENETIC DISEASES

#21
20220025399
2022-01-27

Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor

#22
20210348190
2021-11-11

ADENO-ASSOCIATED VIRUS (AAV) SEROTYPE 8 SEQUENCES, VECTORS CONTAINING SAME, AND USES THEREFOR

#23
20210324431
2021-10-21

Production Of Odd Chain Fatty Acid Derivatives In Recombinant Microbial Cells

#24
20210284974
2021-09-16

COMPOSITIONS AND METHODS FOR THE TREATMENT OF ORNITHINE TRANSCARBAMYLASE DEFICIENCY

#25
20210230648
2021-07-29

Arginine supplementation to improve efficiency in gas fermenting acetogens

#26
20210230623
2021-07-29

Methods of altering seed weight and seed oil content by manipulating alpha-carboxyl-transferase (a-CT) activity via carboxyl-transferase interaction (CTI) protein expression

#27
20210205421
2021-07-08

Messenger RNA therapy for the treatment of ornithine transcarbamylase deficiency

#28
20210054347
2021-02-25

Microorganism for producing ornithine and process for producing ornithine using them

#29
20200377866
2020-12-03

Compositions useful in treatment of ornithine transcarbamylase (OTC) deficiency

#30
20200308557
2020-10-01

FUSION PROTEINS

#31
20200308556
2020-10-01

Ornithine transcarbamylase coding polyribonucleotides and formulations thereof

#32
20200299652
2020-09-24

Polynucleotides encoding ornithine transcarbamylase for the treatment of urea cycle disorders

#33
20200283799
2020-09-10

ADENO-ASSOCIATED VIRUS (AAV) SEROTYPE 8 SEQUENCES, VECTORS CONTAINING SAME, AND USES THEREFOR

#34
20200270657
2020-08-27

Production of malonyl-CoA derived products via anaerobic pathways

#35
20200190486
2020-06-18

Microorganisms for producing putrescine or ornithine and process for producing putrescine or ornithine using them

#36
20200181584
2020-06-11

Compositions and methods for treating ornithine transcarbamylase deficiency

#37
20200172923
2020-06-04

Multimeric coding nucleic acid and uses thereof

#38
20200016278
2020-01-16

Stable gene transfer to proliferating cells

#39
20190365926
2019-12-05

Polynucleotides and vectors for the expression of transgenes

#40
20190292563
2019-09-26

Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor

#41
20190249191
2019-08-15

Multimeric coding nucleic acid and uses thereof

#42
20190248846
2019-08-15

MITOCHONDRIAL PROTEINS CONSTRUCTS AND USES THEREOF

#43
20190136274
2019-05-09

Microorganisms having putrescine productivity and process for producing putrescine using the same

#44
20190127765
2019-05-02

Altered host cell pathway for improved ethanol production

#45
20190071651
2019-03-07

Compositions useful in treatment of ornithine transcarbamylase (OTC) deficiency

#46
20190017068
2019-01-17

Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor

#47
20180236047
2018-08-23

MRNA for use in treatment of human genetic diseases

#48
20180187222
2018-07-05

Microorganisms for producing putrescine or ornithine and process for producing putrescine or ornithine using them

#49
20180135030
2018-05-17

Compositions useful in treatment of ornithine transcarbamylase (OTC) deficiency

#50
20180105850
2018-04-19

L-ornithine production in eukaryotic cells

#51
20180103619
2018-04-19

Disease model pig exhibiting stable phenotype, and production method thereof

#52
20180051262
2018-02-22

Messenger UNA molecules and uses thereof

#53
20180008680
2018-01-11

Messenger RNA therapy for the treatment of ornithine transcarbamylase deficiency

#54
20170314041
2017-11-02

Multimeric coding nucleic acid and uses thereof

#55
20170306354
2017-10-26

Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor

#56
20170226545
2017-08-10

Microorganism of genus having an ability to produce L-arginine and a method for producing L-arginine using the same

#57
20170216456
2017-08-03

Stable Gene Transfer to Proliferating Cells

#58
20170159083
2017-06-08

Arginine supplementation to improve efficiency in gas fermenting acetogens

#59
20170088861
2017-03-30

Altered host cell pathway for improved ethanol production

#60
20170088858
2017-03-30

Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor

#61
20170051259
2017-02-23

Compositions useful in treatment of ornithine transcarbamylase (OTC) deficiency

#62
20170021037
2017-01-26

Compositions useful in treatment of ornithine transcarbamylase (OTC) deficiency

#63
20170002386
2017-01-05

Microorganisms having putrescine productivity and process for producing putrescine using the same

#64
20160298103
2016-10-13

Enzymatic systems for carbon fixation and methods of generating same

#65
20160201088
2016-07-14

Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor

#66
20160153030
2016-06-02

Cyanobacteria saxitoxin gene cluster and detection of cyanotoxic organisms

#67
20160130567
2016-05-12

MESSENGER UNA MOLECULES AND USES THEREOF

#68
20160101160
2016-04-14

mRNA for use in treatment of human genetic diseases

#69
20160075745
2016-03-17

Mitochondrial proteins constructs and uses thereof

#70
20160067321
2016-03-10

Method for treating pancreatic cancer with vaccine

#71
20150176027
2015-06-25

Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor

#72
20150139953
2015-05-21

Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor

#73
20150004217
2015-01-01

mRNA for use in treatment of human genetic diseases

#74
20140004577
2014-01-02

Microorganisms for producing putrescine and method for producing putrescine using same

#75
20130344545
2013-12-26

Microorganisms having improved ornithine-producing ability and method for producing ornithine using the same

#76
20130323766
2013-12-05

Production of malonyl-CoA derived products via anaerobic pathways

#77
20120301947
2012-11-29

Enzymatic systems for carbon fixation and methods of generating same

#78
20120157717
2012-06-21

METHODS AND COMPOSITIONS FOR PRODUCING LINEAR ALKYL BENZENES

#79
20120142756
2012-06-07

mRNA for use in treatment of human genetic diseases

#80
20120070868
2012-03-22

Production of odd chain fatty acid derivatives in recombinant microbial cells

#81
20110129842
2011-06-02

CYANOBACTERIA SAXITOXIN GENE CLUSTER AND DETECTION OF CYANOTOXIC ORGANISMS

#82
20100041108
2010-02-18

Method for producing L-methionine by fermentation

#83
20090227030
2009-09-10

Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor

#84
20080226641
2008-09-18

Outer surface proteins, their genes, and their use

#85
20080118931
2008-05-22

Stabilized Ornithine Transcarbamylase and Immunoassay Method for Ornithine Transcarbamylase Using the Same

#86
20080075740
2008-03-27

Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor

#87
20080075737
2008-03-27

Adeno-associated virus (AAV) serotype 8 sequences, vectors containing the same, and uses therefor

#88
20060188955
2006-08-24

Gene targets for enhanced carotenoid production

#89
20060121558
2006-06-08

Gene targets for enhanced carotenoid production

#90
20060104990
2006-05-18

Outer surface proteins, their genes, and their use

#91
20050214944
2005-09-29

In vivo homologous sequence targeting in cells

#92
20050089849
2005-04-28

Expression vector containing urea cycle enzyme gene, transformant thereof, and use of transformant for protein over-expression